
P.E.I. Humane Society feeling the pinch as the price of drugs for animals climbs
CBC
The P.E.I. Humane Society says it is doing far more fundraising than it used to, and rising expenses — including the cost of animal medications — are a big reason why.
Ashley Travis, the organization’s development and communications co-ordinator, said the price of drugs has seen a “steep increase” in recent years, from pain management products to medications used to reduce anxiety.
She said it’s not only medications the shelter uses in-house that are getting more expensive, but also drugs used at veterinary clinics the society partners with across the Island.
“This is something that does deeply concern us moving forward, because we are on the cusp of greatly expanding our facility, and so as more animals come into our care, cost rising is something we have to look at strategically,” Travis told CBC News.
Travis said the increased prices haven’t affected the shelter’s ability to provide care, but they have added pressure.
The society isn't aware of the exact reasons for the increases, Travis said, but she noted that, much like basic supplies and food, the price of medications may be affected by general inflation.
Beyond inflation, the Canadian Veterinary Medical Association (CVMA) says shortages are also driving up the cost.
At a recent news conference in Ottawa, the association called on the federal government to regulate veterinary drug prices, warning of a “severe decline” in the availability of many essential medications like antibiotics, sedatives and vaccines.
Trevor Lawson, a past CVMA president who's now a large-animal veterinarian in Shubenacadie, N.S., said he has noticed a worsening supply of drugs over the last five to seven years.
The association estimates Canada has seen a 40 per cent decline in registered veterinary medications.
“That’s become a real concern for colleagues across Canada,” Lawson said. “It, at times, has limited our options for treatment of common diseases.”
Lawson said Canada is a small market compared to many other countries, and that has made it harder to keep products here. Smaller markets in Europe are seeing similar challenges.
Lawson said some products that were available earlier in his career are no longer licensed for use because their registrations have lapsed. Canada isn’t seeing many new products come to market either.
When medications that are typically available suddenly disappear, he said veterinarians are forced to find alternatives, like looking to the human supply chain.













